Mats Remberger

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

Katarina Le Blanc, Francesco Frassoni, Lynne M. Ball et al. · The Lancet · 2008 · 2.7K citations

Regenerative Medicine, Mesenchymal Stem Cells, Cell Therapy +13

A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: a report from the Nordic Bone Marrow Transplantation Group

Olle Ringdén, Tapani Ruutu, Mats Remberger et al. · Blood · 1994 · 340 citations · Full text

Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studies

Gèrard Socié, Reginald A. Clift, Didier Blaise et al. · Blood · 2001 · 279 citations · Full text

Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation

Tapani Ruutu, Britta Eriksson, Kari Remes et al. · Blood · 2002 · 247 citations · Full text

Increased Risk of Chronic Graft-Versus-Host Disease, Obstructive Bronchiolitis, and Alopecia With Busulfan Versus Total Body Irradiation: Long-Term Results of a Randomized Trial in Allogeneic Marrow Recipients With Leukemia

Olle Ringdén, Mats Remberger, Tapani Ruutu et al. · Blood · 1999 · 211 citations